高清不卡日本v二区在线,天天综合网天天综合,激情丁香五月天婷婷水蜜桃视频,91精品免费久久久久久久久,手机看片久久久久久久久,日日夜夜嫩草,日本不卡 在线视频,欧美亚洲日韩,高潮歹无毛免费观看视频,天天综合网7799日日夜夜永,欧美日本国产日韩激情视频 ,久久久无码精品亚洲日韩蜜桃,日夜夜天天人人综合网,91蜜桃长长久久,国产精品精品一区在线发布,一级a毛片免费观看久久精品

In the U.S., Authorized Representatives (ARs) are not responsible for handling all issues related to medical devices on behalf of manufacturers. Their primary role is to serve as a liaison between the manufacturer and the U.S. Food and Drug Administration (FDA). This includes ensuring that the manufacturer's device complies with FDA regulations, facilitating the submission of required documents, and addressing regulatory inquiries.

While ARs assist with the initial registration and regulatory submissions, they do not manage all operational aspects. Manufacturers retain responsibility for day-to-day issues such as product quality, adverse event reporting, and compliance with post-market requirements. ARs can support manufacturers by helping navigate regulatory challenges, but they do not replace the manufacturer's obligation to manage and monitor their product in the U.S. market.

Additionally, ARs are instrumental in ensuring that all regulatory documentation is accurate and up-to-date, which helps in mitigating potential issues with FDA compliance. However, manufacturers must stay engaged in ongoing regulatory activities and address any emerging issues directly to maintain compliance and ensure market success

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn